Qualcomm Inc (QCOM34)
B3 Stock Exchange · Brazil · prices in BRL · close of 27 Oct 2026
Key indicators
| Last close | BRL 81.45 |
|---|---|
| 52-week range | 52.70 – 110.01 |
| Return, 1 month / 3 months | −7.1% / +8.6% |
| Return, 1 year / 3 years | −2.0% / +88.1% |
| Trend | Uptrend |
| RSI (14) | 59 |
| Volatility (1 year) | 55.8% |
| Worst drawdown (1 year) | -40.7% |
| Average daily value traded | 2.04M BRL |
| Dividend yield | 4.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Qualcomm is a technology company based in San Diego, California, that designs chips and related hardware for mobile devices and other connected products. Its Snapdragon line of processors and modems powers smartphones and tablets made by many device manufacturers. The company also licenses its wireless technology patents to handset makers, earning royalties on the devices they produce. Its customers include phone makers, network equipment suppliers and automotive and internet-of-things device companies around the world.
Qualcomm Inc is represented on the B3 Stock Exchange in Brazil by a Brazilian depositary receipt (BDR) under the code QCOM34, with its price quoted in Brazilian reais (BRL). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Qualcomm Inc (QCOM34) trades on the B3 Stock Exchange in Brazil. It last closed at BRL 81.45 on 27 October 2026.
Its price-based Market X-Ray is 56 out of 100 (a fair price profile), ranking 562 of 1,455 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 2.0% and over the last three months it rose 8.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on B3 Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 57 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 12.3% | ||
| From 52-week high | -22.8% | ||
| Momentum | 68 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 8.6% | ||
| 6-month return | 33.8% | ||
| 12-month return, skipping the last month | 5.5% | ||
| Stability (higher is calmer) | 26 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 55.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -40.7% | ||
| Liquidity | 79 · Strong | Trades actively. | |
| Average daily value traded | 2.04M BRL | ||
| Zero-volume days | 0.0% | ||
| Income | 60 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 4.9% | ||
| Years with dividends | 6 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | +8.6% |
|---|---|
| 1 month | −7.1% |
| 3 months | +8.6% |
| 6 months | +33.8% |
| 1 year | −2.0% |
| 3 years | +88.1% |
| 5 years | +43.7% |
Signals
| 50-day / 200-day average | 75.56 / 72.55 |
|---|---|
| Golden / death cross (60 days) | Golden, 19 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 3.55 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 1 Jun 2026 | USD 0.2681 |
| 3 Mar 2026 | USD 0.2627 |
| 2 Dec 2025 | USD 0.2767 |
| 2 Sep 2025 | USD 0.2681 |
| 3 Jun 2025 | USD 0.2747 |
| 28 Feb 2025 | USD 0.2762 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on B3 Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.